The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Malykhin F.Т.
Stavropol State Medical University Ministry of Health of Russia, Stavropol, Russia
Baturin V.A.
Kafedra otorinolaringologii, kafedra klinicheskoĭ farmakologii, bakteriologii, allergologii i immunologii Stavropol'skoĭ gosudarstvennoĭ meditsinskoĭ akademii
Possible side effects of drugs in elderly patients with chronic obstructive pulmonary disease and comorbidity
Journal: Therapeutic Archive. 2016;88(3): 100‑107
Views: 6456
Downloaded: 2382
To cite this article:
Malykhin FТ, Baturin VA. Possible side effects of drugs in elderly patients with chronic obstructive pulmonary disease and comorbidity. Therapeutic Archive.
2016;88(3):100‑107. (In Russ.)
https://doi.org/10.17116/terarkh2016883100-107
The papers gives data on the positive effects and adverse reactions of drugs used to treat chronic obstructive pulmonary disease (COPD) and its comorbidity, first of all cardiovascular disease. The authors present alternative points of views based on both the data available in the literature and their findings. They propose to modify pharmacotherapy for COPD in the presence of comorbidity in patients of old age groups.
Authors:
Malykhin F.Т.
Stavropol State Medical University Ministry of Health of Russia, Stavropol, Russia
Baturin V.A.
Kafedra otorinolaringologii, kafedra klinicheskoĭ farmakologii, bakteriologii, allergologii i immunologii Stavropol'skoĭ gosudarstvennoĭ meditsinskoĭ akademii
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.